Skip to main content

Advertisement

Fig. 1 | Molecular Brain

Fig. 1

From: AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat

Fig. 1

Induction of CTA by a rotatory stimulus or intra-vestibular nuclei microinjection of AVP and the effects of the V1bR antagonist (n = 10). a, indication of the microinjection area in the VN (Nissl staining). b, induction of CTA by AVP microinjection into the VN and the blocking effect of V1bR antagonist SSR149415. c, induction of CTA after rotatory stimulus and the blocking effect of SSR149415 microinjection into the VN. d, induction of CTA after AVP intraperitoneal injection (i.p.) and the blocking effect of SSR149415 microinjection into the VN. * P < 0.05, ** P < 0.01, vs. vehicle; # P < 0.05, ## P < 0.01 vs. AVP 10 ng or 30 ng groups, respectively; Δ P < 0.05, vs. AVP (i.p.) used alone

Back to article page